User: Aplantex
The global plant-based bioactive compounds market, particularly for flavonoids ($1.2B, 11% CAGR), is expanding rapidly, driven by demand for sustainable ingredients in pharmaceuticals, nutraceuticals, and cosmetics. Canada’s reliance on imported active ingredients (60% from Asia) underscores the need for local biomanufacturing. Aplantex, a Quebec-based green biotechnology company, leverages duckweed’s rapid growth and sustainability to produce high-value phytochemicals but faces bottlenecks in low transformation efficiency (~1%) and lengthy clone selection (10 months).
This project, a collaboration between Aplantex and Université Laval, develops a high-throughput, genomics-based platform integrating CRISPR/Cas9 transformation, multi-omics (genomics, transcriptomics, metabolomics), hyperspectral imaging, and AI-driven trait prediction to enhance duckweed clone selection. Key objectives include: (1) achieving =5% transformation efficiency, (2) generating comprehensive omics and imaging datasets, and (3) building AI models for non-destructive trait detection with high accuracy. This reduces selection time from 10 to 2 months, significantly increasing throughput and addressing the critical efficiency bottleneck. The commercialization pathway involves deploying the platform in Aplantex’s Montreal R&D pipeline, supported by a 10–15 person team and venture capital funding. An upcoming industrial demonstrator will scale production, enabling Aplantex to meet client demands for high-value clones and expand its pipeline. Intellectual property is secured through exclusive rights for Aplantex’s strain protocols and non-exclusive licensing for general tools, with no IP conflicts.
Benefits to Canada include reduced import reliance, enhancing supply chain security, and job creation in the biotech sector. Duckweed’s low resource use (90% less land/water) supports sustainability, aligning with Canada’s Biomanufacturing Strategy. The project trains highly qualified personnel and shares open-access datasets, advancing Canada’s research ecosystem. Aplantex gains a competitive edge in the bioactive market, driving economic growth and positioning Canada as a leader in green biotechnology.